From HBV RNA to Core-Related Antigen: Novel Viral Biomarkers to Guide Treatment Management & Clinical Outcome Prediction

Time: 1:30 pm
day: Day One


• Assessing the development of novel serum markers that can assess the replicative and transcriptional activity of HBV

• Exploring the use of viral biomarkers in treatment stopping criteria

• Understanding the role of viral biomarkers in predicting clinical outcomes